Editorial Comment from Dr Miyata and Dr Sakai to Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1442-2042|22|6|597-597

ISSN： 0919-8172

Source： INTERNATIONAL JOURNAL OF UROLOGY, Vol.22, Iss.6, 2015-06, pp. : 597-597

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial Comment from Dr Wu to Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 6, 2015-06 ,pp. : 596-596

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 6, 2015-06 ,pp. : 590-595

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial Comment

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 2, 2015-02 ,pp. : 187-187

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial Comment from Dr Wagenlehner to Hospital admissions after transrectal ultrasound‐guided biopsy of the prostate in men diagnosed with prostate cancer: A database analysis in England

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 2, 2015-02 ,pp. : 186-186

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial Comment from Dr Schiavina and Dr Borghesi to Postoperative prostate‐specific antigen monitoring interval for radical prostatectomy patients with low recurrence risk

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 9, 2015-09 ,pp. : 886-886

John Wiley & Sons Inc

Access to resources Recommend Favorite